From the Guidelines
Phlebotomy Indication for Secondary Polycythemia
Phlebotomy is indicated for secondary polycythemia when the hematocrit level exceeds the normal range, with the goal of reducing it to a target level.
- The target hematocrit level for phlebotomy in secondary polycythemia is generally considered to be less than 45% 1, although this may need to be individualized based on the patient's symptoms and risk factors.
- For example, a lower hematocrit cutoff of 42% may be appropriate for female patients or those with progressive or residual vascular symptoms 1.
- Phlebotomy should be performed under careful conditions with appropriate and monitored fluid replacement to avoid both hypotension and fluid overload 1.
- The goal of phlebotomy is to reduce the risk of thrombotic complications, which are more common at higher hematocrit levels 1.
- In addition to phlebotomy, other treatments such as aspirin and cytoreductive therapy may be considered in certain cases, such as in patients with low-risk polycythemia vera 1.
From the Research
Indications for Phlebotomy in Secondary Polycythemia
- Phlebotomy is indicated for secondary polycythemia when the hematocrit level exceeds 54% 2
- This threshold is based on current Canadian guidelines, which recommend regular laboratory monitoring and discontinuing testosterone replacement therapy (TRT) or reducing the dose if the hematocrit exceeds 54% 2
- A study of men with testosterone-deficient men treated with intramuscular testosterone cypionate found that 10% of men had a hematocrit ≥54%, and 33.3% had a hematocrit ≥50% during therapy 3
- Another study found that hemoglobin concentrations of 180 g/L or more (calculated hematocrit, ≥54%) were measured at 25% of appointments in men on TRT who presented for blood donation 2
Hematocrit Levels and Phlebotomy
- A hematocrit level of ≥54% is considered an indication for phlebotomy in patients with secondary polycythemia 2
- However, some studies suggest that phlebotomy may not be sufficient to maintain a hematocrit below 54% in all patients, particularly those with persistent elevations in hemoglobin levels 2, 4
- The optimal hematocrit target for phlebotomy in secondary polycythemia is not well established, but a level <45% is often recommended to prevent adverse outcomes 4, 5